Manuscripts
Showing 1589 manuscripts.
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
Citation
Kristin Baltrusaitis, Jenny Huang, Barbara Heckman, Sarah Buisson, Dwight E. Yin, Ryan Milligan, Allison Agwu, Shawn Ward, Rohan Hazra, Carolyn Bolton-Moore, Conn Harrington, Aditya H. Gaur, Rodica M. Van Solingen-Ristea, IMPAACT 2017 Team, Cynthia C. McCoig, Adeola Adeyeye, Jared Kneebone, Vasiliki Chounta, Christiana Smith-Anderson, Elizabeth D. Lowenthal, Andres Camacho-Gonzalez, Jennifer Chapman, Ellen Chadwick, Rachel Ohrenschall, Allison Bearden, Katherine Calabrese, Herta Crauwels. Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study. Lancet HIV. 2024. 11: e222-e232. PMID: 38538161Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV
Citation
Roger Shapiro, Jeff Stringer, Grace Malonga, Renee Browning, Nahida Chakhtoura, Blandina Theophil Mmbaga, Tsungai P Mhembere, Ayotunde Omoz-Oarhe, Beatrice Nagaddya, Megeshinee Naidoo, Risa M Hoffman, Lee Fairlie, Shahin Lockman, Sean Brummel, IMPAACT 2010/VESTED Study Team, Lauren Ziemba, Anne Coletti, Lameck Chinula. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. Journal of the International AIDS Society. 2024. 97: 150-155. PMID: 39742354Year
2024
Journal
Journal of the International AIDS Society
Study
IMPAACT 2010
Safety and pharmacokinetics of lopinavir/ritonavir oral solution in preterm and term infants starting before 3 months of age
Citation
Adrie Bekker, Jincheng Yang, Jiajia Wang, Mark F. Cotton, Mae Cababasay, Lubbe Wiesner, Jack Moye, Renee Browning, Firdose L. Nakwa, Helena Rabie, Avy Violari, Mark Mirochnick, Tim. R Cressey, Edmund V. Capparelli. Safety and pharmacokinetics of lopinavir/ritonavir oral solution in preterm and term infants starting before 3 months of age. Pediatric Infectious Disease Journal. 2024. 43: 355-360. PMID: 38190642Year
2024
Journal
Pediatric Infectious Disease Journal
Study
P1106
Safety and pharmacokinetics of oral and long-actinginjectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre,open-label, non-comparative, dose-finding st
Citation
Aditya H. Gaur, Edmund V. Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A Marzinke, Cynthia McCoig, Rodica M. Van Solingen-Ristea, Sisinyana Ruth Mathiba, Adeola Adeyeye, John H. Moye, Barbara Heckman, Elizabeth D. Lowenthal, Shawn Ward, Ryan Milligan, Pearl Samson, Brookie M. Best, Conn M. Harrington, Susan L. Ford, Jenny Huang, Herta Crauwels, Kati Vandermeulen, Allison L. Agwu, Christiana Smith-Anderson, Andres Camacho-Gonzalez, Pradthana Ounchanum, Jared L. Kneebone, Ellen Townley, Carolyn Bolton Moore, IMPAACT 2017 Team. Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2024. 11: e211-e221. PMID: 38538160Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV
Citation
Betsy D. Kennard, Larry K. Brown, Kristin Baltrusaitis, Miriam Chernoff, Graham J. Emslie, Jessica Jones, Sarah Buisson, Jaime Deville, Megan Wilkins, Amber Bunch, Chivon McMullen Jackson, Christy Beneri, David E. Shapiro, IMPAACT 2002 Team. Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV. Cognitive Therapy and Research. 2024. 48: 781-790. PMID: 39664885Year
2024
Journal
Cognitive Therapy and Research
Study
IMPAACT 2002
Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants
Citation
John W. Sleasman, Guglielmo M. Venturi, Bernard M. Fischer, Julie J. Kim-Chang, Richard Barfield, Cliburn Chan, Kristina De Paris, Li Yin, Maureen M. Goodenow. Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants. Frontiers in Immunology. 2024. 15: 1443886. PMID: 39328414Year
2024
Journal
Frontiers in Immunology
Maternal-Child Human Immunodeficiency Virus Clinical Trials Networks across the Ages
Citation
Sharon Nachman. Maternal-Child Human Immunodeficiency Virus Clinical Trials Networks across the Ages. Clinics in Perinatology. 2024. 51: 935-949. PMID: 39487030Year
2024
Journal
Clinics in Perinatology
Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032
Citation
Kristina M. Brooks, Kristin Baltrusaitis, Diana F. Clarke, Sharon Nachman, Jennifer Jao, Murli U. Purswani, Allison Agwu, Christy Beneri, Jaime G. Deville, Kathleen M. Powis, Alice M. Stek, Ahizechukwu C. Eke, David E. Shapiro, Edmund Capparelli, Elizabeth Greene, Kathleen George, Dwight E. Yin, Patrick Jean-Philippe, Nahida Chakhtoura, Frederic Bone, Kira Bacon, Benjamin Johnston, Christina Reding, Kathryn Kersey, Rita Humeniuk, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2032 Study Team. Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032. Journal of Infectious Diseases. 2024. 230: 878-888. PMID: 38839047Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2032
Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children
Citation
Matthew S. Kelly, Coleen K. Cunningham, Elizabeth J. McFarland, Mark J. Giganti, Jane C. Lindsey, Charlotte Perlowski, Jennifer L. Libous, Patrick Jean-Philippe, Jack Moye, Ruth A. Karron, Peter L. Collins, Ursula J. Buchholz. Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children. Open Forum Infectious Diseases. 2024. 11: ofae679. PMID: 39610407Year
2024
Journal
Open Forum Infectious Diseases
Study
P1114, IMPAACT 2000, IMPAACT 2011, IMPAACT 2012, IMPAACT 2013, IMPAACT 2018
Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life
Citation
Deborah Persaud, Ellen G. Chadwick, Jennifer Jao, IMPAACT P1115 Team, Mark F. Cotton, Yvonne Bryson, Anne Coletti, Theodore D. Ruel, Stephen A. Spector, Christina Reding, Kira Bacon, Diane Costello, Charlotte Perlowski, Maria Leticia Santos Cruz, Josphat Kosgei, Sai Majji, Bryan S. Nelson, Dwight E. Yin, Camlin Tierney, Patrick Jean-Philippe. Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life. Clinical Infectious Diseases. 2023. 76: e744-e747. PMID: 36031390Year
2023
Journal
Clinical Infectious Diseases
Study
P1115